These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 214045

  • 21. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G].
    Schmersahl P, Rüdiger G.
    Z Hautkr; 1975 Feb 01; 50(3):105-12. PubMed ID: 179231
    [Abstract] [Full Text] [Related]

  • 22. HLA antigens in patients with recrudescent herpes simplex infections.
    Legendre C, Russell AS, Jeannet M.
    Tissue Antigens; 1982 Jan 01; 19(1):85-9. PubMed ID: 6280337
    [Abstract] [Full Text] [Related]

  • 23. Cellular immune response in genital herpes simplex virus infection.
    Corey L, Reeves WC, Holmes KK.
    N Engl J Med; 1978 Nov 02; 299(18):986-91. PubMed ID: 211414
    [Abstract] [Full Text] [Related]

  • 24. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V, Fanta D, Reiss-Gutfreund RJ, Janisch H, Berger R.
    Wien Klin Wochenschr; 1977 Mar 18; 89(6):201-3. PubMed ID: 191994
    [Abstract] [Full Text] [Related]

  • 25. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H, Bernstein JM, Riepenhoff-Talty M, Cohen E, Orsini F, Ogra PL.
    Clin Exp Immunol; 1986 Dec 18; 66(3):507-15. PubMed ID: 2436840
    [Abstract] [Full Text] [Related]

  • 26. Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment.
    Wade JC, Day LM, Crowley JJ, Meyers JD.
    J Infect Dis; 1984 May 18; 149(5):750-6. PubMed ID: 6327849
    [Abstract] [Full Text] [Related]

  • 27. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
    Burchett SK, Corey L, Mohan KM, Westall J, Ashley R, Wilson CB.
    J Infect Dis; 1992 May 18; 165(5):813-8. PubMed ID: 1314868
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunity to herpes simplex virus in children receiving treatment for acute lymphoblastic leukaemia (ALL).
    Tellez PA, Odom L, Hayward AR.
    Clin Exp Immunol; 1985 Dec 18; 62(3):525-9. PubMed ID: 3002690
    [Abstract] [Full Text] [Related]

  • 30. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.
    Srivastava R, Khan AA, Chilukuri S, Syed SA, Tran TT, Furness J, Bahraoui E, BenMohamed L.
    J Virol; 2017 Jul 15; 91(14):. PubMed ID: 28468883
    [Abstract] [Full Text] [Related]

  • 31. Cell-mediated immunity to herpes virus type-1 in patients with recurrent corneal herpes simplex.
    Hammer H, Dobozy A.
    Acta Ophthalmol (Copenh); 1980 Apr 15; 58(2):161-6. PubMed ID: 6249065
    [Abstract] [Full Text] [Related]

  • 32. [Analysis of protective mechanism against herpes simplex virus (HSV) infection in mice (author's transl)].
    Nagafuchi S.
    Fukuoka Igaku Zasshi; 1980 Jul 15; 71(7):353-64. PubMed ID: 6260612
    [No Abstract] [Full Text] [Related]

  • 33. Clinical efficacy of a herpes simplex subunit vaccine.
    Cappel R, Sprecher S, De Cuyper F, De Braekeleer J.
    J Med Virol; 1985 Jun 15; 16(2):137-45. PubMed ID: 2989419
    [Abstract] [Full Text] [Related]

  • 34. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD, Bell RB, Aurelian L.
    Cell Immunol; 1980 Dec 15; 56(2):526-39. PubMed ID: 6258811
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.
    Jacobs RP, Aurelian L, Cole GA.
    J Immunol; 1976 Jun 15; 116(6):1520-5. PubMed ID: 58037
    [Abstract] [Full Text] [Related]

  • 38. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS, Rouse BT.
    J Immunol; 1983 Jul 15; 131(1):479-84. PubMed ID: 6223080
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
    Klein RJ, Buimovici-Klein E, Moser H, Moucha R, Hilfenhaus J.
    Arch Virol; 1981 Jul 15; 68(2):73-80. PubMed ID: 6264897
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of human lymphocytes by Herpes simplex virus antigens.
    Starr SE, Karatela SA, Shore SL, Duffey A, Nahmias AJ.
    Infect Immun; 1975 Jan 15; 11(1):109-12. PubMed ID: 163788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.